Population Reports articles from August 1995

Population Reports archives from August 1995

New era for injectables. (injectable contraceptives)
August 1, 1995... In the next few years millions of couples throughout the world will be offered the choice of injectable contraceptives. Reassuring research findings, approval of the 3-month injectable in the US, and the introduction of new monthly injectables...

Research and regulatory approval. (of injectable contraceptives)
August 1, 1995... Three events signal a new era for injectable contraceptives: * A multinational epidemiological study by the World Health Organization (WHO) produced largely reassuring findings about the 3-month injectable depot medroxyprogesterone acetate...

Use of injectables. (injectable contraceptives)
August 1, 1995... Except in a handful of countries, few women use injectable contraceptives compared with other methods. Statistics from donor agencies, however, suggest that use is increasing. About 12 million women in developing countries use injectable...

Effectiveness and reversibility. (of injectable contraceptive drugs)
August 1, 1995... Injectable contraceptives combine almost complete effectiveness with reliable reversibility. Most clinical trials report less than 1 pregnancy per 100 women in the first year of use (39, 41, 271, 277, 336, 338, 340, 342). Thus injectables are...

Side effects and complications. (of injectable contraceptive drugs)
August 1, 1995... Disruption of regular menstrual bleeding and amenorrhea are the most common side effects of injectables and the main reasons that women stop using them. Also, most women report weight gain. Far fewer women report a variety of other side effects,...

More evidence in the cancer debate. (cancer risk factors in injectable contraceptive usage)
August 1, 1995... In the 1980s several epidemiologic studies assessed the risk of cancer among women using injectables. As noted (see p. 3), the largest and most carefully controlled of these studies was the WHO Collaborative Study of Neoplasia and Steroid...

The user's perspective on injectables. (injectable contraceptives)(includes related information)
August 1, 1995... Women's attitudes toward progestin-only injectables largely reflect their feelings about the privacy and convenience of injections and menstrual bleeding disruptions. These feelings in turn reflect not only the attributes and physiological...

Noncontraceptive health benefits. (for injectable contraceptives)
August 1, 1995... Injectables have several health benefits in addition to preventing unintended pregnancy. They help to prevent endometrial and possibly ovarian cancer (see p. 15). They also may help women with anemia and sickle-cell disease. Also, like other...

Counseling issues. (in injectable contraceptive usage)
August 1, 1995... Good counseling helps clients choose and use contraceptives. What do clients need to know to make an informed choice of injectables and to use them successfully? Programs answer this question in counseling guidelines appropriate for their...

Communicating with the public. (about injectable contraceptive drugs)
August 1, 1995... Injectable contraceptives have great potential, but they also have been controversial. People need to know what is true or scientifically proven about injectables and what is incorrect or unproven. Also, they need to know the advantages and...

Maximizing access and quality. (of injectable contraceptives)(includes related information)
August 1, 1995... The potential increase in the availability of injectables offers family planning programs the opportunity to set up accessible, good-quality services. Some programs have offered injectables for many years and now are strengthening services....

Bibliography. (for articles on injectable contraceptives)(Bibliography)
August 1, 1995... Bibliography An asterisk (*) denotes an item that was particularly useful in the preparation of this issue of Population Reports. [1] ABDEL-SAYED, W.S., TOPPOZADA, H.K., SAID S.A., and EL-SAYED, O.K. Some metabolic and hormonal changes in...

DMPA at a glance. (depot medroxyprogesterone acetate, also known as Depo-Provera)
August 1, 1995... Convenient. Each 150 mg injection of DMPA (depot medroxyprogesterone acetate) (brand name Depo-Provera[R]) protects against pregnancy for 3 months. Effective. One of the most effective family planning methods: less than 1 pregnancy per...

Counseling about injectables: Depo-Provera and Noristerat. (injectable contraceptives)
August 1, 1995... INJECTABLE CONTRACEPTIVES are convenient, private, and very effective. This guide will help you, the family planning provider, tell your clients about the 3-month injectable called Depo-Provera@ (DMPA) or the 2-month injectable called Noristerat...